DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT DPT LABORATORIES, LTD. AND PEPLIN, INC.Development and Clinical Supply Agreement • October 17th, 2008 • Peplin Inc • Pharmaceutical preparations • New Jersey
This Development And Manufacturing Agreement (this “Agreement”), effective as of this October 23, 2007 (the “Effective Date”), is made by and between Peplin, Inc., a Delaware corporation with its principal place of business at 6475 Christie Avenue, Emeryville, California 94608 (“COMPANY”), and DPT Laboratories, Ltd., a Texas Limited Partnership with its principal place of business at 307 E. Josephine, San Antonio, Texas 78215 (“DPT”).
MASTER SERVICES AGREEMENTMaster Services Agreement • October 17th, 2008 • Peplin Inc • Pharmaceutical preparations • New Jersey
THIS CLINICAL MASTER SERVICES AGREEMENT (the “Agreement”) is entered into as of the effective date, March 6, 2008 (“Effective Date”), by and between TKL Research, Inc., whose offices are located at 365 W. Passaic Street, Rochelle Park, NJ 07662 (together with its, agents and/or affiliates, “TKL”), and Peplin Operations Pty Ltd. located at Level 2, 1 Breakfast Creek Rd, Newstead, Queensland 4006, Australia (“Sponsor”).
CLINICAL SERVICES MASTER AGREEMENTClinical Services Master Agreement • October 17th, 2008 • Peplin Inc • Pharmaceutical preparations • Queensland
THIS CLINICAL SERVICES MASTER AGREEMENT (this “Master Agreement”) is entered into as of this 1st day of June, 2005, by and between Peplin Operations Pty Ltd ACN 093 317 367 (“Sponsor”) of Level 2, 1 Breakfast Creek Road, Newstead in the state of Queensland, Australia and Omnicare CR, Inc., (“Omnicare CR”) a Delaware corporation.
SEPARATION AGREEMENTSeparation Agreement • October 17th, 2008 • Peplin Inc • Pharmaceutical preparations • California
This Separation Agreement (“Agreement”), dated as of September 2, 2008 (the “Effective Date”), is made by and among Peplin, Inc. (the “Company” or “Peplin”) and Philip Moody (“Executive”) (collectively the “Parties” or, individually, a “Party”).
